Pharma Focus Asia

30/03/2026

AI is changing how pharmaceutical teams approach protein–ligand interactions—and collaboration is the next big step.

In 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚 (𝐈𝐬𝐬𝐮𝐞 𝟔𝟐), 𝐑𝐨𝐛𝐢𝐧 𝐑ö𝐡𝐦, 𝐂𝐄𝐎 & 𝐂𝐨-𝐅𝐨𝐮𝐧𝐝𝐞𝐫 𝐨𝐟 𝐀𝐩𝐡𝐞𝐫𝐢𝐬, explains how fine-tuning co-folding AI models using proprietary datasets can significantly improve prediction accuracy while keeping sensitive data secure.

From enabling better structural insights to supporting faster target validation, this approach is helping teams make smarter, data-driven decisions in early drug discovery.

Plus, federated learning is opening doors for multiple pharma companies to collaborate—without sharing raw data.

𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐬𝐭𝐨𝐫𝐲 𝐢𝐧 𝐈𝐬𝐬𝐮𝐞 𝟔𝟐 𝐨𝐟 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚:
https://www.pharmafocusasia.com/information-technology/fine-tuning-ai-models-for-molecular

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐞𝐁𝐨𝐨𝐤 𝐟𝐫𝐨𝐦 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐭𝐨𝐝𝐚𝐲:
https://www.pharmafocusasia.com/magazine

27/03/2026

The future of cell and gene therapies (CGTs) in APAC is being written today—and regulation is at the heart of it.

In 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚 – 𝐈𝐬𝐬𝐮𝐞 𝟔𝟐, Wei Xia ANG (Senior Regulatory Compliance Lead, Cytiva) shares a compelling perspective on how countries across the Asia-Pacific are adapting global regulatory frameworks while building systems tailored to their unique needs.

From fast-track approvals and cross-border partnerships to manufacturing challenges and quality innovation, this article highlights the real-world complexities shaping next-generation therapies.

💡 Whether you're in biotech, regulatory affairs, or pharma leadership, this is a must-read for understanding where the industry is headed.

📥 𝐆𝐞𝐭 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐬𝐭𝐨𝐫𝐲:
https://www.pharmafocusasia.com/manufacturing/navigating-the-future-the-regulatory

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐞𝐁𝐨𝐨𝐤 𝐟𝐫𝐨𝐦 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐧𝐨𝐰: https://www.pharmafocusasia.com/magazine

26/03/2026

The future of pharmaceutical innovation is no longer built inside a single company—it’s powered by ecosystems.

In 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚 – 𝐈𝐬𝐬𝐮𝐞 𝟔𝟐, Lavinia Woodward, Director at Excelra, breaks down how the industry is shifting from traditional R&D models to collaborative, tech-enabled networks.

💡 𝐃𝐢𝐝 𝐲𝐨𝐮 𝐤𝐧𝐨𝐰?
✔ Over half of new drugs now come from biotechs
✔ AI is dramatically reducing development timelines
✔ Pharma companies are increasingly orchestrating global partnerships

This isn’t just evolution—it’s a complete reset of how medicines are discovered and delivered.

𝐆𝐞𝐭 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐬𝐭𝐨𝐫𝐲 𝐚𝐧𝐝 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
https://www.pharmafocusasia.com/magazine

👉 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐭𝐨 𝐝𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐞𝐁𝐨𝐨𝐤 𝐧𝐨𝐰: https://www.pharmafocusasia.com/magazine

25/03/2026

Pharmaceutical education is no longer limited to physical labs.

A new article in 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚 – 𝐈𝐬𝐬𝐮𝐞 𝟔𝟐 by Stephen Hilton and Blanka (née Szulc) Hilton shows how digital twin laboratories and AI-powered avatars are making high-quality training accessible from anywhere in the world.

Imagine learning advanced techniques like HPLC or flow chemistry through immersive virtual environments—with real-time feedback, multilingual guidance, and hands-on simulation.

These technologies are helping:
🔬 Students gain practical skills remotely
🌍 Increase inclusion across global communities
🌱 Reduce carbon footprint through virtual collaboration
💼 Prepare professionals for industry-ready roles

This is the future of pharmaceutical training—and it’s already here.

👉 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞:
https://www.pharmafocusasia.com/research-development/redefining-pharmaceutical-research

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐞𝐁𝐨𝐨𝐤 𝐟𝐫𝐨𝐦 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚 𝐨𝐧 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐭𝐨𝐝𝐚𝐲: https://www.pharmafocusasia.com/magazine

25/03/2026

Biologic drug safety starts with smarter testing.

Our upcoming live webinar dives into how 𝐍𝐞𝐱𝐭 𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐒𝐞𝐪𝐮𝐞𝐧𝐜𝐢𝐧𝐠 (𝐍𝐆𝐒) is transforming adventitious agent detection—helping teams improve accuracy, reduce risks, and meet evolving regulatory expectations.

🗓 𝐀𝐩𝐫𝐢𝐥 𝟗, 𝟐𝟎𝟐𝟔
🕒 𝟏𝟏:𝟑𝟎 𝐀𝐌 𝐈𝐒𝐓

Learn how to:
✔ Replace traditional testing methods with advanced NGS approaches
✔ Handle challenging samples and unknown contaminants
✔ Stay compliant with updated ICH Q5A guidelines

Bonus: Get access to expert guides on sterility testing, cell banking, and mycoplasma detection.

Don’t miss this opportunity to stay ahead in biologics safety.

𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐧𝐨𝐰: https://industry.pharmafocusasia.com/clientemailblast/1774255412-Charles-River-Laboratories.html

24/03/2026

Did you know that billions' worth of pharmaceutical products are wasted every year—not because of lack of demand, but due to logistics gaps?

In 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚 – 𝐈𝐬𝐬𝐮𝐞 𝟔𝟐, 𝐒𝐰𝐚𝐫𝐮𝐩 𝐁𝐨𝐬𝐞, 𝐅𝐨𝐮𝐧𝐝𝐞𝐫 & 𝐂𝐄𝐎, 𝐂𝐞𝐥𝐜𝐢𝐮𝐬 𝐋𝐨𝐠𝐢𝐬𝐭𝐢𝐜𝐬, explains how cold chain failures, compliance issues, and last-mile delivery challenges are impacting patient care—and what the industry can do about it.

Smarter logistics powered by technology like AI, IoT, and blockchain are transforming how medicines move—making supply chains more reliable, transparent, and sustainable.

💡 The future of pharma depends on delivering every vial and tablet safely, efficiently, and on time.

https://www.pharmafocusasia.com/strategy/why-pharma-products-still-go-to-waste

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐞𝐛𝐨𝐨𝐤 𝐧𝐨𝐰 𝐚𝐧𝐝 𝐬𝐭𝐚𝐲 𝐚𝐡𝐞𝐚𝐝 𝐢𝐧 𝐩𝐡𝐚𝐫𝐦𝐚 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: https://www.pharmafocusasia.com/magazine

24/03/2026

Most prescriptions focus on how much medicine to take—but what about when to take it?

In this insightful piece, 𝐃𝐫. 𝐀𝐬𝐚𝐰𝐚𝐫𝐢 𝐏𝐚𝐠𝐚𝐫𝐞 (𝐁𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐢𝐚𝐧, 𝐔𝐖 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞) highlights a crucial gap in modern drug development:
👉 Our bodies respond not just to dose but also to timing and patterns of exposure.

Receptors—the targets of many drugs—are dynamic and adaptive. Continuous exposure can lead to tolerance, while carefully timed dosing may preserve sensitivity and improve outcomes.

💡 It’s a shift from thinking of the body as a container… to understanding it as a responsive, time-sensitive system.

This perspective could change how we design therapies for chronic diseases, optimize dosing schedules, and improve patient care.

Want to dive deeper into this game-changing idea?

Visit our website to read the full article and see what the future of medicine could look like.
https://www.pharmafocusasia.com/articles/rethinking-how-medicines-work

23/03/2026

The pharma industry is moving fast—stay updated with insights that matter.

𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚’𝐬 𝐞𝐦𝐚𝐢𝐥 𝐧𝐞𝐰𝐬𝐥𝐞𝐭𝐭𝐞𝐫 delivers a curated mix of articles, interviews, news, tech trends, research insights, and the latest magazine—all in one place. Perfect for professionals who want reliable, relevant updates without the noise.

Subscribe now and share it with your colleagues to keep your network informed and connected.

https://industry.pharmafocusasia.com/e-newsletters/1773828132-Mar-26.html

👉 𝐇𝐞𝐚𝐝 𝐭𝐨 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐚𝐧𝐝 𝐬𝐢𝐠𝐧 𝐮𝐩 𝐭𝐨𝐝𝐚𝐲! https://www.pharmafocusasia.com/subscribe

23/03/2026

Drug discovery has long relied on a system that takes more than it gives.

In this thought-provoking piece, 𝐉𝐞𝐬𝐬𝐞 𝐆𝐫𝐞𝐲 𝐄𝐚𝐠𝐥𝐞 and 𝐃𝐫. 𝐒𝐚𝐛𝐚𝐡 𝐔𝐥-𝐇𝐚𝐬𝐚𝐧 highlight why extractive practices—past and present—are not only unethical but also holding science back.

From overlooked Indigenous contributions to modern data gaps, the consequences are real: incomplete research, mistrust, and missed breakthroughs.

👉 𝐋𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞 𝐚𝐧𝐝 𝐭𝐚𝐤𝐞 𝐚𝐜𝐭𝐢𝐨𝐧 𝐡𝐞𝐫𝐞: https://www.pharmafocusasia.com/articles/the-value-in-decolonising-drug-discovery

18/03/2026

The Asia-Pacific region is rapidly emerging as a key player in neurodegenerative disease research—and it’s transforming how innovation happens.

In this article, 𝐒𝐢𝐦𝐨𝐧𝐚 𝐋𝐚𝐦𝐛𝐞𝐫𝐭𝐢𝐧𝐢, 𝐒𝐞𝐧𝐢𝐨𝐫 𝐆𝐥𝐨𝐛𝐚𝐥 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐏𝐫𝐨𝐠𝐫𝐚𝐦𝐬 𝐋𝐞𝐚𝐝 & 𝐈𝐧𝐝𝐞𝐩𝐞𝐧𝐝𝐞𝐧𝐭 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐚𝐧𝐭, shares how APAC is strengthening its role through advanced clinical trials, translational science, and supportive regulatory frameworks.

With rising cases of Alzheimer’s and Parkinson’s, and growing investments in cutting-edge therapies, APAC is helping drive faster, more inclusive, and more effective drug development.

What does this mean for the future of neuroscience and pharma innovation?

𝐑𝐞𝐚𝐝 𝐦𝐨𝐫𝐞 𝐨𝐧 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://www.pharmafocusasia.com/articles/apacs-rising-role-in-neurodegenerative

18/03/2026

Developing high-performing cell lines doesn’t have to slow you down.

The 𝐆𝐢𝐛𝐜𝐨 𝐂𝐇𝐎𝐯𝐚𝐧𝐭𝐚𝐠𝐞 𝐆𝐒 𝐂𝐞𝐥𝐥 𝐋𝐢𝐧𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐊𝐢𝐭 𝐛𝐲 𝐓𝐡𝐞𝐫𝐦𝐨 𝐅𝐢𝐬𝐡𝐞𝐫 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 helps you generate productive clones faster, achieve high protein yields, and maintain consistent quality—all while keeping costs under control.

From early development to production, stay on track and deliver results with confidence.

👉 𝐋𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞 𝐡𝐞𝐫𝐞:
https://industry.pharmafocusasia.com/clientemailblast/1773662633-Thermo-Fisher-Scientific.html

17/03/2026

How medicines reach the body is becoming just as important as the medicine itself.

In this article by 𝐒𝐚𝐢𝐧𝐚 𝐁𝐢𝐣𝐚𝐧𝐳𝐚𝐝𝐞𝐡 (𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲 𝐨𝐟 𝐓𝐞𝐡𝐫𝐚𝐧), we break down how cutting-edge drug delivery systems—like nanotechnology, smart materials, and long-acting implants—are improving treatment outcomes and patient experience.

𝐈𝐦𝐚𝐠𝐢𝐧𝐞 𝐭𝐡𝐞 𝐭𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬 𝐭𝐡𝐚𝐭
✔ Target only diseased cells
✔ Release drugs at the right time
✔ Reduce side effects and dosing frequency

That future is already taking shape.

👉 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐭𝐨 𝐫𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐚𝐧𝐝 𝐬𝐭𝐚𝐲 𝐮𝐩𝐝𝐚𝐭𝐞𝐝 𝐨𝐧 𝐩𝐡𝐚𝐫𝐦𝐚 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: https://www.pharmafocusasia.com/articles/novel-developments-in-drug-delivery-systems

Explore novel drug delivery advances—from nanobots to smart therapeutics. Discover breakthroughs, benefits, and future impact. Learn more now!